Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurodex for Pain in Diabetic Neuropathy
NCT00113620Phase 3Completed
- Sponsor
- Avanir Pharmaceuticals
- Start
- Jul 2005
- Primary completion
- Feb 2007
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dextromethorphan + quinidine in diabetic neuropathy (3 arms), sponsored by Avanir Pharmaceuticals. Primary endpoint: Mean change from baseline in the daily pain intensity rating scale at 13 weeks. Started Jul 2005; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT00113620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113620.